Leaner agency Infarmed may reduce product prices and cap profits in Portugal
This article was originally published in Scrip
The Portuguese National Authority of Medicines and Health Products, Infarmed, may implement some "administrative measures", such as price reductions for healthcare products and revision of profit margins for pharmacies and wholesalers in response to the national economic situation in Portugal.
You may also be interested in...
As companies undergo pharmacovigilance inspections from a growing multitude of regulatory authorities from around the globe, a senior pharmaceutical industry executive discusses how her company has been handling this complex and challenging task.
While inspection interviews can be stressful for drug firms, a Dutch pharmacovigilance inspector reassures companies that any responses made during the process cannot undo any good work they have already done. And they can also correct any wrong answers later on.
The Saudi Food & Drug Authority looks at the number of individual case safety reports (ICSRs) submitted by a company, among other risk-based factors, when drawing up its list for routine pharmacovigilance inspections.